Circulating cytokine profile in anti-neutrophilic cytoplasmatic autoantibody-associated vasculitis: prediction of outcome? (original) (raw)
Decreased Neutrophil Apoptosis in Quiescent ANCA-Associated Systemic Vasculitis
Thomas Hellmark
PLoS ONE, 2012
View PDFchevron_right
Monocyte chemoattractant protein 1 is a prognostic marker in ANCA-associated small vessel vasculitis
omran bakoush
Mediators of inflammation, 2009
View PDFchevron_right
Pathogenesis of anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis
Shaun Andrew
Clinical & Experimental Immunology, 2011
View PDFchevron_right
Neutrophil activation in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis and large-vessel vasculitis
Dr. Bhargavi Duvvuri
Arthritis Research & Therapy
View PDFchevron_right
Monocyte activation and relationship to anti-proteinase 3 in acute vasculitis
Agneta Wikman
Nephrology Dialysis Transplantation, 2003
View PDFchevron_right
Intermediate monocytes in ANCA vasculitis: increased surface expression of ANCA autoantigens and IL-1β secretion in response to anti-MPO antibodies
Fionnuala Hickey
Scientific Reports, 2015
View PDFchevron_right
Phagocytosis of apoptotic cells by macrophages in anti-neutrophil cytoplasmic antibody-associated systemic vasculitis
Thomas Hellmark
Clinical & Experimental Immunology, 2012
View PDFchevron_right
Comparison of disease activity measures for anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis
Cees Kallenberg
Annals of the Rheumatic Diseases, 2008
View PDFchevron_right
Targeting B Lymphocytes as Therapy for ANCA-Associated Vasculitis
Ulrich Specks
Rheumatic Disease Clinics of North America, 2007
View PDFchevron_right
Inhibition of neutrophil-mediated production of reactive oxygen species (ROS) by endothelial cells is not impaired in anti-neutrophil cytoplasmic autoantibodies (ANCA)-associated vasculitis patients
Cgm Kallenberg
Clinical & Experimental Immunology, 2000
View PDFchevron_right
Animal models of anti-neutrophil cytoplasmic antibody associated vasculitis
Cees Kallenberg
Kidney International, 1998
View PDFchevron_right
Intracellular Cytokine Production in ANCA-associated Vasculitis: Low Levels of Interleukin-10 in Remission Are Associated with a Higher Relapse Rate in the Long-term Follow-up
Zdenka Hruskova
Archives of Medical Research, 2009
View PDFchevron_right
Antineutrophil cytoplasmic antibodies (ANCA): Role in disease pathogenesis, diagnosis, and monitoring ANCA associated vasculitis
Gilda SANDRI
Indian Journal of Rheumatology, 2015
View PDFchevron_right
Serum cytokine changes in vasculitis
Claude Lambert
Immunology
View PDFchevron_right
Increased circulating levels of proteinase 3 in patients with anti-neutrophilic cytoplasmic autoantibodies-associated systemic vasculitis in remission
Sophie Ohlsson
Clinical and Experimental Immunology, 2003
View PDFchevron_right
New insights into the pathogenesis of antineutrophil cytoplasmic autoantibody-associated vasculitis
Cees Kallenberg
Autoimmunity Reviews, 2002
View PDFchevron_right
Circulating B Cells, Plasma Cells, and Treg Associate with ANCA Levels in ANCA-associated Vasculitis
loreto fernandez
Kidney International Reports
View PDFchevron_right
Impaired phagocytosis and reactive oxygen species production in phagocytes is associated with systemic vasculitis
Sophie Ohlsson
Arthritis Research & Therapy, 2016
View PDFchevron_right
Autoantibodies against glomerular endothelial cells in anti-neutrophil cytoplasmic autoantibody-associated systemic vasculitis
Johanna Westra
Nephrology, 2009
View PDFchevron_right
Novel territory for neutrophils in the pathogenesis of ANCA-associated vasculitides
Cees Kallenberg
Nephrology Dialysis Transplantation, 2009
View PDFchevron_right
Sustained Monocyte Activation in Clinical Remission of Systemic Vasculitis
Agneta Wikman
Inflammation, 2008
View PDFchevron_right
Autoantibodies in systemic vasculitis
Jan Willem Cohen Tervaert
Australian and New Zealand Journal of Medicine, 1991
View PDFchevron_right
Antineutrophil cytoplasm antibodies and vasculitis
Michael Dillon
Archives of Disease in Childhood, 1997
View PDFchevron_right
New pathophysiological insights and treatment of ANCA-associated vasculitis
Jan Willem Cohen Tervaert
Kidney International, 2011
View PDFchevron_right
Pathophysiology of ANCA-associated small vessel vasculitis
Cees Kallenberg
Current rheumatology reports, 2010
View PDFchevron_right
Serum proteins reflecting inflammation, injury and repair as biomarkers of disease activity in ANCA-associated vasculitis
R. Spiera
Annals of the Rheumatic Diseases, 2013
View PDFchevron_right
Immune Cells Profiling in ANCA-Associated Vasculitis Patients—Relation to Disease Activity
Magdalena Krajewska
Cells, 2021
View PDFchevron_right
Review article: The role of CD4 + T cells in ANCA-associated systemic vasculitis
Wayel Abdulahad
Nephrology, 2009
View PDFchevron_right
Renal involvement in anti-neutrophil cytoplasmic autoantibody associated vasculitis
Veronica Tello Aguirre
Autoimmunity Reviews, 2013
View PDFchevron_right
Neutrophil-related gene expression and low-density granulocytes associated with disease activity and response to treatment in ANCA-associated vasculitis
Ulrich Specks, Cees Kallenberg
Arthritis & rheumatology (Hoboken, N.J.), 2015
View PDFchevron_right
Mechanisms of Disease: pathogenesis and treatment of ANCA-associated vasculitides
Cees Kallenberg
Nature Clinical Practice Rheumatology, 2006
View PDFchevron_right